transparent foil (Qiagen)
Qiagen is a verified supplier 
Qiagen manufactures this product 
93
Structured Review
Qiagen
transparent foil
Transparent Foil, supplied by Qiagen, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transparent+foil/Tape+Pads/pm40405715-61-43-47
Average 93 stars, based on 22 article reviews
Transparent Foil, supplied by Qiagen, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transparent+foil/Tape+Pads/pm40405715-61-43-47
Average 93 stars, based on 22 article reviews
transparent foil - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: Development of Cagrilintide, a Long-Acting Amylin Analogue Article Snippet: Each solution is aliquoted (200 μL/ well; n = 4) to a microtiter plate (OptiPlate-96, White Opaque 96- well Microplate, PerkinElmer, US) sealed with a Article Title: Structure, Self-Association, and Aggregation Properties of a Long-Acting Amylin Receptor Agonist. Article Snippet: Pharmacokinetic (PK) properties of therapeutic peptides can be extended through covalent conjugation to albuminbinding fatty acids.. The present study examines the effects of fatty acid conjugation and vehicle composition on structure, selfassociation pattern, and aggregation propensity of an amylin analogue.. Small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and circular dichroism (CD) were applied to elucidate structural features and self-association patterns, whereas the propensity toward formation of amyloid fibrils under extreme stressful conditions was assessed based on thioflavin T fluorescence. Formulation:Article Title: Rational Development of Stable PYY 3-36 Peptide Y 2 Receptor Agonists. Article Snippet: Purpose The anorectic effect of PYY3–36 makes it a potential pharmacological weight loss treatment.. Modifications of the endogenous peptide to obtain commercially attractive pharmacological and biophysical stability properties are examined.. Methods Half-life extended PYY3–36 analogues were prepared and examined regarding Y2-receptor potency as well as biophysical and stability properties. |